GlassScriptPhysician profile
Derek Craig Higgins
NPI 1568611655
$3,610.94
in general payments reported to CMS, 2019-2025
27 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $1,307 · 2021: $301 · 2022: $1,281 · 2023: $67.69 · 2024: $212 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371 · Education: $22.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.68 |
| Education | $22.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,169.25 | 2019-2020 | |
| Nevro Corp. | $1,132.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $214.76 | 2020-2025 | Relistor |
| Medtronic, INC. | $182.81 | 2023-2024 | Synchromedii |
| Collegium Pharmaceutical, INC. | $137.15 | 2020-2023 | Belbuca |
| Almatica Pharma LLC | $120.79 | 2020-2022 | |
| Stimwave Technologies Incorporated | $108.79 | 2019 | |
| Protega Pharmaceutials INC | $71.75 | 2025 | Roxybond |
| Piramal Critical Care | $60.75 | 2020-2023 | |
| Scilex Pharmaceuticals INC. | $48.23 | 2019 | |
| Biodelivery Sciences International, INC. | $42.25 | 2020-2021 | |
| Spr Therapeutics, INC | $37.22 | 2019 | |
| Redhill Biopharma INC. | $32.56 | 2020-2021 | |
| Virtus Pharmaceuticals LLC | $30.38 | 2021 | |
| Angiodynamics, INC. | $28.21 | 2025 | Auryon Laser System 100-120 Vac |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otto Bock Healthcare LP | $22.63 | 2024 | |
| Vertos Medical, INC. | $22.56 | 2024 | Mild Device Kit |
| Shionogi INC | $20.91 | 2019 | |
| Boston Scientific Corporation | $17.17 | 2019 | |
| Emergent Biosolutions INC. | $16.91 | 2019 | |
| Bioventus LLC | $16.23 | 2021 | |
| Metacel Pharmaceuticals LLC | $13.53 | 2022 | |
| Orthogenrx INC. | $13.34 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.93 | 2021 | |
| Tersera Therapeutics LLC | $12.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.24 | 2019 | |
| Zyla Life Sciences, INC. | $12.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.